Actively Recruiting
Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures
Led by Helse Stavanger HF · Updated on 2026-04-30
170
Participants Needed
1
Research Sites
285 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A hip fracture is a large burden to the patient with increased mortality, pain and increased need for daily assistance. Trochanteric fractures of the femur (FTF) represents about 35% of the hip fractures. Today FTFs are mainly treated with internal fixation using sliding hips screws (SHS) or intramedullary nail (IMN), whilst hip arthroplasty (THA/HA) is rarely used. Despite advances in the design of the internal fixation implants there is a high failure rate, in particular in cases of FTFs classified as unstable fractures. Since the introduction of hip arthroplasty in femoral neck fractures there has been a reduction in complication rates, early mobilization and shorter hospital stays. The primary objective of this project is to investigate if treatment with hip arthroplasty in unstable FTFs will increase the postoperative mobility, give a better general health outcome for the patient, better quality of life and reduce re-operation rate for the patients compared to those operated with the traditional IMN.
CONDITIONS
Official Title
Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years or older
- American Society of Anesthesiology Score (ASA) less than 4
- Able to walk with or without aid before injury
- Radiologically confirmed unstable trochanteric hip fracture (AO 31A2.2 - 3.3)
- Written consent obtained from patient or next of kin
You will not qualify if you...
- Previous hip surgery on either side
- Unable to walk before injury
- Not living in the hospital's care area
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stavanger University Hospital
Stavanger, Norway
Actively Recruiting
Research Team
T
Thomas Abel Woldeyesus, MD
CONTACT
A
Ane Djuv, MD., PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here